ArticleJournal of Cancer2020
Sex Differences and Adverse Effects between Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer.
Open access · goldAbstract read
In one paragraph
Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.
- Clinical efficacy and safety of Chinese herbal injections in combination with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of 140 randomized controlled trials.Frontiers in oncology · 2024Pooled it
- Methodology of murine lung cancer mimics clinical lung adenocarcinoma progression and metastasis.Scientific reports · 2025Article
- Effect of Gender on Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Real-World Study.Biomedicines · 2025Article
- Effect of gamma knife stereotactic radiotherapy on the hematological system in patients with advanced lung cancer and its therapeutic effect.American journal of cancer research · 2025Article
- Huaier suppresses cell viability, migration and invasion in human non-small cell lung cancer via lncRNA DLEU2/miR-212-5p/ELF3 axis.International journal of medical sciences · 2024Article
- LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers.Frontiers in molecular biosciences · 2023Review
- Effectiveness of immunological agents in non-small cell lung cancer.Cancer reports (Hoboken, N.J.) · 2023Review
- Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications.Frontiers in oncology · 2023Review
- Changes in Body Weight, Body Composition, Phase Angle, and Resting Metabolic Rate in Male Patients with Stage IV Non-Small-Cell Lung Cancer Undergoing Therapy.Medicina (Kaunas, Lithuania) · 2022Article
- Dietary Habits Are Related to Phase Angle in Male Patients with Non-Small-Cell Lung Cancer.Current oncology (Toronto, Ont.) · 2022Article
- The Effectiveness and Safety of Cinobufotalin Injection as an Adjunctive Treatment for Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.Evidence-based complementary and alternative medicine : eCAM · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 9 institutions in 4 countries.
Theodora TsioudaPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Chrisanthi SardeliDepartment of Pharmacology & Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantinos PorpodisPulmonary Department, G. "Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Maria PilikidouPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Georgios ApostolidisPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Krystallia KyrkaPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Angeliki MiziouPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Konstantina KyrkaPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Zoi TsingerliotiPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Souzana PapadopoulouPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Anta HevaPulmonary Department, "Theageneio" Cancer Hospital, Thessaloniki, Greece.
Charilaos Koulouris3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Dimitrios Giannakidis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Konstantina Boniou3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Isaak Kesisoglou3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Anastasios Vagionas3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Christoforos Kosmidis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Christina Sevva3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
George PapazisisDepartment of Pharmacology & Clinical Pharmacology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Alexandru Marian GoganauGeneral Surgery Clinic 1, University of Medicine and Pharmacy of Craiova, Craiova County Emergency Hospital, Craiova, Romania.
Konstantinos Sapalidis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Kosmas TsakiridisThoracic Surgery Department, "Interbalkan" European Medical Center, Thessaloniki, Greece.
Stavros TryfonPulmonary Department (NHS), G.H. "G. Papanikolaou" Thessaloniki, Thessaloniki, Greece.
Michalis PlatanasUrology Department (NHS), General Hospital of Giannitsa, Giannitsa, Greece.
Sofia BakaOncology Department, "Interbalkan" European Medical Center, Thessaloniki, Greece.
Bojan ZaricInstitute for Pulmonary Diseases of Vojvodina, Faculty of Medicine, University of Novi Sad, Serbia.
Branislav PerinInstitute for Pulmonary Diseases of Vojvodina, Faculty of Medicine, University of Novi Sad, Serbia.
Savvas PetanidisDepartment of Pulmonology, I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.
Paul Zarogoulidis3rd Department of Surgery, "AHEPA" University Hospital, Aristotle University of Thessaloniki, Medical School, Thessaloniki, Greece.
Theageneio General Hospital · GRAHEPA University Hospital · GRAristotle University of Thessaloniki · GRInterbalkan Medical Center · GRG. Papanikolaou General Hospital · GRInstitute for Pulmonary Diseases of Vojvodina · RSSechenov University · RUUniversity of Medicine and Pharmacy of Craiova · ROUniversity of Novi Sad · RS
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
adverse effectschemotherapyimmunotherapyLung cancer
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.